Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Dave Willis, chief strategy officer for Clarius Mobile Health, providers of mobile ultrasound units, reviewed how mobile solutions can overcome a multitude of barriers in providing high quality healthcare.
Telemedicine is able to provide point-of-service care in medical emergencies. A recent study, published in Neurology, found telemedical concussion services and face-to-face evaluations agreed on diagnoses 100 percent of the time.
While healthcare costs continued to rise at other facilities, one Netherlands hospital was able to lower costs by 8 percent in a single year while improving quality. The credit goes to a value-based care strategy focusing on everything from closer coordination on cardiovascular patients to keeping more experienced physicians in the emergency department.
ReWalk Robotic, producers of wearable robotic exoskeletons for patients with spinal cord injuries, has been commissioned by the U.S. Department of Veterans Affairs (VA) to provide 28 exoskeleton system to be used in a multi-center clinical trial.
A recent study, published in Lancet Respiratory Medicine, examined a point-of-care testing strategy capable of providing test results within an hour, dramatically speeding up the time between diagnosis and administering treatment.
Vaccines prevent measles, mumps and chicken pox—but researchers have a new target. A new vaccine, being developed by scientists at the University of California, San Diego, hopes to prevent acne.
An arbitration panel recently awarded $18.3 million to the bankruptcy estate of a Dallas company that claimed it was fraudulently lured into a licensing deal to sell a medical laser machine used by doctors.
Identifying patients at high risk of developing prediabetes is an important first step in preventing further progression of the disease. A tool, presented at the Endocrine Society's 99th annual meeting, shows promise in pinpointing patients in need of early intervention.
The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.
